Subject: PMNC
Subject: calprotectin
Subject: liver cirrhosis
Subject: spontaneous bacterial peritonitis (SBP)
Year: 2021
Type: Article
Title: Diagnostic Potential of Calprotectin for Spontaneous Bacterial Peritonitis in Patients Withliver Cirrhosis and Ascites
Author: Lichoska Josifovikj, Fana
Author: Grivcheva Stardelova, Kalina
Author: Todorovska, Beti
Author: Genadieva Dimitrova, Magdalena
Author: Joksimovikj, Nenad
Author: Andreevski, Vladimir
Author: Trajkovska, Meri
Author: Serafimovski, Vladimir
Abstract: The development of spontaneous bacterial peritonitis (SBP) is a serious and life-threatening condition in patients with cirrhosis and ascites. The aim of this study was to determine the diagnostic potential of calprotectin in ascites, for SBP in patients with liver cirrhosis and ascites before and after antibiotic treatment and to compare the mean values of calprotectin in ascites in patients with and without SBP. This prospective-observational study was comprised of 70 patients with cirrhosis and ascites, divided into two groups, the SBP and the non-SBP group. Quantitative measurements of calprotectin in ascites was completed with the Quantum Blue Calprotectin Ascites test (LF-ASC25), using the Quantum Blue Reader. The average value of calprotectin in the SBP group was 1.5 ± 0.40 μg / mL, and in the non-SBP group it was lower (0.4 ± 0.30). The difference between the mean values was statistically significant with p <0.05. The mean value of calprotectin in ascites before therapy among the SBP group was 1.5 ± 0.4, and after antibiotic therapy, the value decreased significantly to 1.0 ± 0.6; the difference between the mean values was statistically significant with p <0.05. ROC analysis indicated that calprotectin contributed to the diagnosis of SBP with a 94.3% sensitivity rating (to correctly identify positives), and the specificity was 62.5%, which corresponded to the value of 0.275. Our research confirmed that ascitic calprotectin was a good predictor, and is significantly associated with the occurrence of SBP in patients with liver cirrhosis. By monitoring the value of calprotectin in ascites on the 7th day of antibiotic treatment, the effectiveness of antibiotic treatment in patients with SBP can be determined.
Publisher: Walter de Gruyter GmbH / Macedonian Academy of Sciences and Arts
Relation: Prilozi (Makedonska akademija na naukite i umetnostite. Oddelenie za medicinski nauki)
Identifier: oai:repository.ukim.mk:20.500.12188/16873
Identifier: http://hdl.handle.net/20.500.12188/16873Identifier: 10.2478/prilozi-2021-0040
Identifier: https://www.sciendo.com/pdf/10.2478/prilozi-2021-0040Identifier: 42
Identifier: 3
